SpectronRx
PrivateLast Round
Early Funding
Apr 2, 2026
Total Funding Raised
$85M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
SpectronRx operates in Healthcare & Life Sciences and is based in Indianapolis, Indiana. Its latest recorded funding round was an Early Funding round in April 2026.
SpectronRx is a radiopharmaceutical company that provides therapeutic and diagnostic isotope solutions as a contract development and manufacturing organization (CDMO).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpectronRx Comparables
Compare SpectronRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AtomVie Global Radiopharma Inc. | 91% | |
| Nucleus RadioPharma | 88% | |
| NorthStar Medical Radioisotopes, LLC | 86% |
For institutional investors. Book with your work email.
SpectronRx Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SpectronRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 52% MoM.
- Apr 2, 2026
$85M raised in early funding round.
For institutional investors. Book with your work email.
SpectronRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SpectronRx's valuation, stock price, and market status.
Is SpectronRx a public or private company?
SpectronRx is a private company.
What is the current stock price of SpectronRx?
SpectronRx is a private company, so its shares have no public market price. Caplight tracks SpectronRx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SpectronRx worth (valuation)?
Valuation information for SpectronRx is not publicly available.
Can I buy SpectronRx stock?
SpectronRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SpectronRx's last funding round?
SpectronRx's most recent funding round was Early Funding on April 2, 2026.
Who are the main investors in SpectronRx?
Key investors in SpectronRx include OrbiMed.
Will SpectronRx IPO soon?
No public IPO plans have been announced for SpectronRx.
How can I track SpectronRx secondary market activity?
Caplight tracks bids, offers, and trades in SpectronRx's shares on secondary markets.